These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 12633170)
21. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW Diabetes; 2005 Nov; 54(11):3252-7. PubMed ID: 16249452 [TBL] [Abstract][Full Text] [Related]
22. The etiology of hypertension in the metabolic syndrome part two: the gene-environment interaction. Sharma V; McNeill JH Curr Vasc Pharmacol; 2006 Oct; 4(4):305-20. PubMed ID: 17073700 [TBL] [Abstract][Full Text] [Related]
23. [108th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 2. Correlation between pulmonary diseases and whole body; (3) sleep apnea syndrome and life style related diseases]. Chin K Nihon Naika Gakkai Zasshi; 2011 Sep; 100(9):2509-16. PubMed ID: 22117343 [No Abstract] [Full Text] [Related]
27. Insulin resistance, the metabolic syndrome and risk of cardiovascular disease: a complex story. Issa BG; Hanna FW Curr Opin Lipidol; 2003 Aug; 14(4):405-7. PubMed ID: 12865741 [No Abstract] [Full Text] [Related]
28. Misclassification of cardiometabolic health when using body mass index categories. Caleyachetty R; Meunnig P; Kengne AP Int J Obes (Lond); 2016 Aug; 40(8):1332. PubMed ID: 27102047 [No Abstract] [Full Text] [Related]
29. Metabolic syndrome: a marker of patients at high cardiovascular risk. Lau DC; Yan H; Dhillon B Can J Cardiol; 2006 Feb; 22 Suppl B(Suppl B):85B-90B. PubMed ID: 16498518 [TBL] [Abstract][Full Text] [Related]
30. Editorial: Managing the cardiovascular risk associated with the metabolic syndrome. Montalto G; Rizzo M; Mikhailidis DP Curr Pharm Des; 2014; 20(31):4941-3. PubMed ID: 24320029 [No Abstract] [Full Text] [Related]
31. Usefulness of plasma glucose and insulin concentrations in identifying patients with insulin resistance. Tuan CY; Abbasi F; Lamendola C; McLaughlin T; Reaven G Am J Cardiol; 2003 Sep; 92(5):606-10. PubMed ID: 12943888 [TBL] [Abstract][Full Text] [Related]
32. Metabolic syndrome: navigating a danger zone of heart risk factors. Health After 50 Sci Am Consum Health; 2015 Sep; 27(8):1-2. PubMed ID: 26685336 [No Abstract] [Full Text] [Related]
33. All-cause and cardiovascular mortality risk estimation using different definitions of metabolic syndrome in Lithuanian urban population. Luksiene D; Baceviciene M; Jureniene K; Bernotiene G; Reklaitiene R; Radisauskas R; Tamosiunas A Prev Med; 2012 Oct; 55(4):299-304. PubMed ID: 23046635 [TBL] [Abstract][Full Text] [Related]
37. The predictive value of metabolic syndrome for cardiovascular and all-cause mortality: Tehran Lipid and Glucose Study. Amouzegar A; Mehran L; Hasheminia M; Kheirkhah Rahimabad P; Azizi F Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27155315 [TBL] [Abstract][Full Text] [Related]
38. Increased mortality among sleepy snorers: a prospective population based study. Lindberg E; Janson C; Svärdsudd K; Gislason T; Hetta J; Boman G Thorax; 1998 Aug; 53(8):631-7. PubMed ID: 9828847 [TBL] [Abstract][Full Text] [Related]
39. [Diagnosis of metabolic syndrome]. Nakamura T; Okauchi Y; Ryo M; Funahashi T; Shimomura I Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1731-6. PubMed ID: 17037307 [No Abstract] [Full Text] [Related]
40. Sleep-Disordered Breathing Is a Stronger Risk Factor for Proliferative Diabetic Retinopathy than Metabolic Syndrome and the Number of Its Individual Components. Shiba T; Takahashi M; Matsumoto T; Hori Y Semin Ophthalmol; 2019; 34(2):59-65. PubMed ID: 30669924 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]